Clinical Trial Update: A Trial Investigating the Effects of Semaglutide on ß-cell Function in Subjects With Type 2 Diabetes [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluated the effects of semaglutide on beta-cell function in subjects with Type 2 Diabetes Mellitus; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED